Robb Knie - 27 Aug 2025 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)

Role: CEO and President, Director
Signature: /s/ Hayley Springer as Attorney-In-Fact for Robb Knie
Issuer symbol: HOTH
Transactions as of: 27 Aug 2025
Net transactions value: -$376,000
Form type: 4
Filing time: 28 Aug 2025, 18:48:36 UTC
Previous filing: 15 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Knie Robb	CEO and President, Director	C/O HOTH THERAPEUTICS, INC. 1177 AVENUE, OF THE AMERICAS, 5TH FLOOR, SUITE 5066, NEW YORK	/s/ Hayley Springer as Attorney-In-Fact for Robb Knie	28 Aug 2025	0001609695

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HOTH	Common Stock	Award	$0	+800,000	+1376%	$0.000000	858,131	27 Aug 2025	Direct	F1
transaction	HOTH	Common Stock	Tax liability	$376,000	-310,744	-36%	$1.21	547,387	28 Aug 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock was issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.